Your browser doesn't support javascript.
loading
Motor unit number estimation by MScanFit in myotonic dystrophies.
Schneider, Christian; Svacina, Martin K R; Kohle, Felix; Sprenger-Svacina, Alina; Fink, Gereon R; Lehmann, Helmar C.
Afiliação
  • Schneider C; Department of Neurology, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany; Department of Neurology, St. Katharinen Hospital, Frechen, Germany. Electronic address: Christian.Schneider@khs-frechen.de.
  • Svacina MKR; Department of Neurology, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Kohle F; Department of Neurology, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Sprenger-Svacina A; Department of Neurology, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Fink GR; Department of Neurology, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany; Cognitive Neuroscience, Research Center Juelich, Institute of Neuroscience and Medicine (INM-3), Juelich, Germany.
  • Lehmann HC; Department of Neurology, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany; Department of Neurology, Klinikum Leverkusen, Leverkusen, Germany.
J Neurol Sci ; 451: 120728, 2023 08 15.
Article em En | MEDLINE | ID: mdl-37478794
BACKGROUND: MScanFit is a new motor unit number estimation (MUNE) technique applied in motor neuron diseases and polyneuropathies to assess clinical progression and underlying disease pathology. So far, its value in myopathies, especially myotonic dystrophies (MD), has not been investigated. METHODS: Motor unit loss and characteristics of patients with genetically confirmed MD type 1 (n = 7) and type 2 (n = 5) were investigated using MScanFit of the abductor pollicis brevis muscle and compared to age-matched healthy controls. MUNE measures were correlated with muscle impairment determined by the MRC sum score and handgrip strength. RESULTS: MScanFit detected motor unit loss in patients with MD (p = 0.017). There was no significant difference in motor unit loss between MD type 1 and type 2 (p = 0.64). CMAP-discontinuities which, when added up, exceed 50% of the CMAP amplitude were reduced in MD patients (p = 0.0284), but motor unit amplitudes were not significantly different (p = 0.0597). The motor unit loss strongly correlated with the MRC sum score (p = 0.014, Rho = 0.678). CONCLUSIONS: Our study shows the feasibility of MScanFit in MD and its potential to serve as a surrogate marker for overall muscle impairment. Motor unit analysis indicates that neurogenic alterations in both MD subtypes might be present.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurônios Motores / Distrofia Miotônica Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Neurol Sci Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurônios Motores / Distrofia Miotônica Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Neurol Sci Ano de publicação: 2023 Tipo de documento: Article